Key highlights
12 May 2023 – 1 mins read
LinkedIn
Twitter
Facebook
Understanding the true impact of living with FOP
This year marks the 17th anniversary since the discovery of the ACVR1 gene was announced, a major scientific milestone in fibrodysplasia ossificans progressiva (FOP) research that helped us understand what causes the condition. On April 23,
Explore more by category
Showing: 1 – 10 of 45 stories
08 March 2021 – 1 mins read
Statement on lanreotide European decentralised procedure
PARIS, FRANCE, 8 March 2021 – Ipsen has learned that Amdipharm Ltd, which is believed to be a subsidiary of Advanz Pharma, has received a positive outcome by the Reference Member State, Denmark, and closure of the Decentralised Procedure, for a generic f
01 March 2021 – 1 mins read
Ipsen announces the arrival of Gwenan White, EVP Communications & Public Affairs
We are pleased to announce the arrival of Gwenan White as Executive Vice President, Communications and Public Affairs, effective 1 March 2021. Based in Boulogne, France, she will be responsible for designing, implementing and managing the communications an
09 December 2020 – 1 mins read
Ipsen and the fight against corruption
Today is International Anti-Corruption Day. We are all aware that corruption has the potential to impact the social and economic development of all companies, societies and countries. That is why we must be unified in our efforts to conduct business with t
01 December 2020 – 2 mins read
Ipsen’s new strategic priorities unveiled at virtual Capital Markets Day event
Today, Ipsen is hosting a virtual Capital Markets Day to launch our new Group strategy which positions us for long-term success by focusing together for patients and society. Four priorities will drive continued growth and bring transformative medicines to
26 November 2020 – 1 mins read
Ipsen – Capital Markets Day Webcast – Tuesday, December 1, 2020
David Loew, Chief Executive Officer, is pleased to host a Capital Markets Day webcast to present the Group’s Strategy on:
Ipsen’s partnership with Marengo
Find out more about how we approach partnerships at Ipsen, where every program is a priority within our pipeline. We sat down with Zhen Su, CEO Marengo, to discuss our partnership and how we undertake a one team approach to accelerate innovation for the pa
Ipsen’s 2022 Integrated Annual Report now available
2022 was a year of focus, momentum and growth at Ipsen. Learn about the progress we made and download the 2022 Integrated Annual Report here.
Collette: finding community through PBC
Collette spent almost 20 years going back and forth between different doctors and treatments, before she was finally diagnosed with PBC.
Caitlin: learning to accept care as a caregiver
In September 2012, when she was 21, Caitlin received news every child dreads: her father had been diagnosed with pancreatic cancer and had been given three months to live.
Steve: taking action against kidney cancer
Steve has been diagnosed with kidney cancer twice. After initial success with a nephrectomy, his cancer returned in January 2018. This time, his doctor said there was no treatment available. “He advised I would probably be put on life-extending drugs,”
Diana: Taking spasticity in stride
Diana was a full-time journalist when, at the age of 34, she experienced a stroke that impacted her movement and left her with spasticity.
Fireside Chat: Innovation and Policy Change in Rare Diseases
The rare disease community continues to strive for innovative solutions to meet patient needs and ensure no person living with a rare disease is left behind.
Applications now open for the 2023 Golden Ticket Competition
As part of our commitment to accelerating transformative research and development, we’re excited to announce that our Golden Ticket Competition is now open! Through our continued partnership with Biolabs, we’re delighted to be offering the brightest mi
Understanding the true impact of living with FOP
This year marks the 17th anniversary since the discovery of the ACVR1 gene was announced, a major scientific milestone in fibrodysplasia ossificans progressiva (FOP) research that helped us understand what causes the condition. On April 23,
Rethinking risk factors this Liver Cancer Awareness Month
Learn how to engage with our campaign and help protect your liver health. Every year, Liver Cancer Awareness Month (LCAM) is an opportunity to bring the sixth most prevalent cancer globally to the forefront of conversation, promoting awareness and the impo